SI
GH icon

Stephens Inc’s Guardant Health GH Stock Holding History

Stephens Inc’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$398K Buy
2,653
+143
+6% +$15.6K ﹤0.01% 970
2026
Q1 		$232K Sell
2,510
-134
-5% -$13.5K ﹤0.01% 1144
2025
Q4 		$270K Buy
+2,644
New +$237K ﹤0.01% 1085
2024
Q1 		– Sell
-11,285
Closed -$305K – 1326
2023
Q4 		$305K Sell
11,285
-461
-4% -$12.1K 0.01% 932
2023
Q3 		$348K Buy
11,746
+2,746
+31% +$96.6K 0.01% 857
2023
Q2 		$322K Buy
+9,000
New +$258K 0.01% 896
2022
Q4 		– Sell
-6,647
Closed -$358K – 1199
2022
Q3 		$358K Sell
6,647
-207
-3% -$10.6K 0.01% 824
2022
Q2 		$276K Sell
6,854
-399
-6% -$19.8K 0.01% 952
2022
Q1 		$480K Sell
7,253
-864
-11% -$59.1K 0.01% 825
2021
Q4 		$812K Sell
8,117
-1,855
-19% -$192K 0.01% 693
2021
Q3 		$1.25M Sell
9,972
-1,685
-14% -$200K 0.02% 578
2021
Q2 		$1.45M Buy
11,657
+1,140
+11% +$153K 0.02% 558
2021
Q1 		$1.6M Sell
10,517
-2,091
-17% -$316K 0.03% 495
2020
Q4 		$1.63M Buy
12,608
+898
+8% +$103K 0.03% 473
2020
Q3 		$1.31M Buy
11,710
+1,608
+16% +$147K 0.03% 480
2020
Q2 		$820K Buy
10,102
+121
+1% +$9.75K 0.02% 572
2020
Q1 		$695K Buy
+9,981
New +$766K 0.02% 566

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Stephens Inc's GH Position: Q2 2026 in Review

Stephens Inc increased its Guardant Health (GH) stake by 5.7% in Q2 2026, buying an estimated $15.6K and bringing the position to 2,653 shares worth $398K. The position accounts for ﹤0.01% of the portfolio, ranked #970.

Stephens Inc first reported a position in GH in Q1 2020 and has held it in 17 quarters since. The position peaked at $1.63M in Q4 2020. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Stephens Inc held 2,653 shares of Guardant Health worth $398K as of Q2 2026.
  • Stephens Inc bought 143 Guardant Health shares in Q2 2026, an estimated $15.6K.
  • Guardant Health made up ﹤0.01% of Stephens Inc's portfolio in Q2 2026, its #970 holding.
  • Stephens Inc first reported a position in Guardant Health in Q1 2020 and has held it in 17 quarters since.
  • Stephens Inc's Guardant Health position peaked at $1.63M in Q4 2020.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Stephens Inc's 13F filing for Q2 2026, filed 29 Jul 2026.